Understanding the Critical Disposition Pathways of Statins to Assess Drug–Drug Interaction Risk During Drug Development: It's Not Just About OATP1B1
出版年份 2012 全文链接
标题
Understanding the Critical Disposition Pathways of Statins to Assess Drug–Drug Interaction Risk During Drug Development: It's Not Just About OATP1B1
作者
关键词
-
出版物
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 92, Issue 5, Pages 584-598
出版商
Springer Nature
发表日期
2012-10-11
DOI
10.1038/clpt.2012.163
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Transporter-Mediated Drug–Drug Interactions Involving OATP Substrates: Predictions Based on In Vitro Inhibition Studies
- (2012) K Yoshida et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Predicting Drug Interaction Potential With a Physiologically Based Pharmacokinetic Model: A Case Study of Telithromycin, a Time-Dependent CYP3A Inhibitor
- (2012) Md L T Vieira et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Prediction of the in vivo OATP1B1-mediated drug–drug interaction potential of an investigational drug against a range of statins
- (2012) Pradeep Sharma et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Pitavastatin: An overview
- (2011) Yasushi Saito ATHEROSCLEROSIS SUPPLEMENTS
- Evaluation of CYP2C8 Inhibition In Vitro: Utility of Montelukast as a Selective CYP2C8 Probe Substrate
- (2011) B. M. VandenBrink et al. DRUG METABOLISM AND DISPOSITION
- Kinetic Characterization of Rat Hepatic Uptake of 16 Actively Transported Drugs
- (2011) Y. Yabe et al. DRUG METABOLISM AND DISPOSITION
- Prediction of the Overall Renal Tubular Secretion and Hepatic Clearance of Anionic Drugs and a Renal Drug-Drug Interaction Involving Organic Anion Transporter 3 in Humans by In Vitro Uptake Experiments
- (2011) T. Watanabe et al. DRUG METABOLISM AND DISPOSITION
- Statin-induced myopathy: a review and update
- (2011) Thura T Abd et al. Expert Opinion On Drug Safety
- Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy
- (2011) Amy Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance
- (2011) Katherine S. Fenner et al. XENOBIOTICA
- The search beyond statins
- (2010) Melinda Wenner Moyer NATURE MEDICINE
- Transporter Pharmacogenetics and Statin Toxicity
- (2009) M Niemi CLINICAL PHARMACOLOGY & THERAPEUTICS
- ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
- (2009) J E Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Physiologically Based Predictions of the Impact of Inhibition of Intestinal and Hepatic Metabolism on Human Pharmacokinetics of CYP3A Substrates
- (2009) Frederique Fenneteau et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
- (2009) Deepak Voora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Different effects of theABCG2c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin
- (2009) Jenni E Keskitalo et al. PHARMACOGENOMICS
- Relationship between Drug/Metabolite Exposure and Impairment of Excretory Transport Function
- (2008) M. J. Zamek-Gliszczynski et al. DRUG METABOLISM AND DISPOSITION
- Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin
- (2008) S. Kitamura et al. DRUG METABOLISM AND DISPOSITION
- Peptide prodrugs: Improved oral absorption of lopinavir, a HIV protease inhibitor
- (2008) Sheetal Agarwal et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics of the CYP 3A Substrate Simvastatin following Administration of Delayed Versus Immediate Release Oral Dosage Forms
- (2008) Marija Tubic-Grozdanis et al. PHARMACEUTICAL RESEARCH
- The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15
- (2008) Jian Wei Deng et al. Pharmacogenetics and Genomics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started